Daewoong Pharmaceutical said Wednesday it held a global academic program for medical professionals, the “Nabota Master Class (NMC) Spring in Korea.”
The 2-night, 3-day event ran from April 13-15 for 74 medical professionals from 13 countries, including Thailand, Brazil and Chile. Sessions were held at Mercure Seoul Magok, COEX Magok, Ewha Womans University Seoul Hospital and Daewoong Pharmaceutical’s Hyangnam plant.
The NMC program is designed to strengthen clinicians’ capabilities and promote academic exchange as the global botulinum toxin market expands. The first day’s lectures covered trends in botulinum toxin procedures and safety, differences in diffusion and duration by product, and examples of combination treatments.
An anatomy session, a key feature of the program, was designed to improve accuracy and safety in botulinum toxin injections. Using cadaver-based training and face painting, instructors explained facial anatomy and injection points, followed by a live demonstration via two-way broadcast and one-on-one hands-on training.
Daewoong said sessions sharing know-how and experience with Nabota’s signature techniques, including Nabolift and Naboglow, drew strong interest.
Participants also toured the Hyangnam plant, where the company introduced its aseptic processes, production facilities and automated logistics system, highlighting Nabota’s manufacturing capabilities.
“Daewoong Pharmaceutical will continue to strengthen brand competitiveness through a global academic platform that expands Nabota’s proprietary techniques and clinical experience,” said Yoon Jun-su, head of the company’s Nabota Business Division.
* This article has been translated by AI.
Copyright ⓒ Aju Press All rights reserved.